🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

💉#Immunisation is one of the most cost-effective interventions available to save lives. Researchers from GHECO & CMMID comment on #WorldImmunizationWeek, their research & the importance of the Expanded Programme on Immunisation. Read 👉bit.ly/3UnuJYY

📣 New article now in Frontiers #Tuberculosis 📣 We held a #workshop to ask experts from countries with a high TB burden what #epi, #impact, #feasibility and #acceptability data they would need to decide whether to introduce new TB #vaccines 🌏🧮 frontiersin.org/articles/10.33…

Did you miss the #UCL/London School of Hygiene & Tropical Medicine #WorldTBDay Symposium this year? Worry not! You can watch all the sessions here 👇 (I would definitely recommend the presentation around 3 hours 42 minutes in if you like #modelling and #vaccines!) youtube.com/watch?v=ClpRth…

New modeling shows the potential impact of #tuberculosis #vaccines M72/AS01E and BCG-revaccination in #India. M72/AS01E could avert 16% cases in Delhi and BCG-revaccination 8.8% Read more bit.ly/4bPCXAd

Fantastic news that new vaccines for #TB will be included in GAVI's future portfolio. Huge credit to Dr Marta Tufet Bayona , her team and Gavi, the Vaccine Alliance ! Glad to support @AllisonPortnoy Rebecca Clark Nick Menzies and all London School of Hygiene & Tropical Medicine CMMID LSHTM TB Centre Vaccine Centre rb.gy/dm4pk8

Subclinical tuberculosis is ~half of prevalent TB, could make people sick and cause transmission So, it is crucial to understand whether new TB vaccines prevent subclinical TB and what it means for global impact Find out how more in our new paper in The Lancet Microbe

LSHTM TB Centre Seminar Series resumes 📅 10th Sept ⏰ 12.45 BST Rebecca Clark "Estimating the epidemiological & economic impact of scaling up a nutritional intervention for TB affected households across India" Do join us in person or online! tinyurl.com/yd3na9yz

Excited to see this out The Lancet Global Health - using new efficacy/safety evidence for DR-TB TPT to estimate epi & econ impact of household contact management. sciencedirect.com/science/articl… @JamesSeddon10 @petedodd24 Nyashadzaishe Mafirakureva Greg Fox London School of Hygiene & Tropical Medicine CMMID LSHTM TB Centre LSHTM AMR Centre LSHTM TB Modelling Group

Emily Kendall Nick Menzies Richard White Ted Cohen Tess Ryckman London School of Hygiene & Tropical Medicine LSHTM TB Centre CMMID LSHTM TB Modelling Group And the original work which this built on is now out too - projecting the health and economic effects of pan-TB (with the same fantastic group of researchers). Thank you to all involved! thelancet.com/journals/langl…

The R package #hmer for calibrating #mathematical models using history matching with emulation has now been downloaded over 10,000 times since its release two years ago! 🎉 cran.r-project.org/web/packages/h…

Support the demands of the global TB community for the development and rollout of new TB vaccines. Join the call, sign the Community Declaration of the 7th Global Forum on TB Vaccines! In Eng, Esp, Fra, Hin, Indon, Por, Rus! 📅 Deadline: Sun, 6 Oct 2024 ✒️bit.ly/7GFTBVcomdecSi…

New #TB vaccines could play an important role in reducing the #TB burden in #PLHIV, as was shown in this mathematical modelling study based on South African data by Tom Sumner and colleagues. London School of Hygiene & Tropical Medicine 🔗👉ow.ly/WVlF50UCoLx

Nutritional care for TB-affected households is likely to be highly cost-effective & could avert a substantial amount of disease and death in India – our paper out now in The Lancet Global Health Rebecca Clark Rein Houben LSHTM TB Modelling Group sciencedirect.com/science/articl…

Household nutritional support can avert 350,000 TB deaths In The Hindu Finn McQuaid & Rebecca Clarke discuss study suggesting nutritional care for #TB patients during treatment could also avert 880,000 new cases in #India by 2035. thehindu.com/sci-tech/scien…

📢Join our next webinar with Boston University School of Public Health's Dr Allison Portnoy who will present on approximating costs for reaching zero-dose children & Kayoko Shioda, PhD, DVM, MPH speaking about tools to identify optimal vaccine dosing schedules.💉 🗓️ 27 February ⏲️ 14.00 GMT 📍Online 👉bit.ly/41cj8iQ

In 2024, 68million people were displaced by humanitarian crises, & are at increased risk of TB, the world's biggest infectious disease killer. We urgently need estimates to identify the scale of this problem & drive our response. We provide initial numbers gh.bmj.com/content/10/3/e…

TB & climate change: World Health Organization (WHO) report out now, building on an analytical framework we developed to explore the intersections and implications for the TB epidemic. Key message? TB should be considered a climate-sensitive disease who.int/publications/i…

Can you believe it’s been 25 years!? Join us on 20 June 2025 at 4pm UK time to celebrate 25 years of the Introduction to Infectious Disease Modelling course by London School of Hygiene & Tropical Medicine and UK Health Security Agency Hear neil_ferguson on What modelling might be like in 25 years, & students' modelling adventures

Could TB vaccine trials be faster, smaller, cheaper? Our new Lancet Respir Med piece argues that including asymptomatic bacteriologically confirmed TB disease in the primary endpoint could be transformative—if the right evidence is generated. doi.org/10.1016/S2213-…